This inventor holds 1 USPTO granted patent and 2 published patent applications and 1 EPO patent. Top assignees: Otsuka Pharmaceutical Company, Limited, University of Bern. Active years: 2010.
Company Filing History:
1 out of 846 
1 out of 26 Years Active: 2010
Title: Andrea Johner: Innovator in Nucleic Acid Sequences
Introduction
Andrea Johner is a notable inventor based in Niederwangen, Switzerland. She has made significant contributions to the field of biotechnology, particularly in the development of novel amino acid and nucleic acid sequences. Her work has implications for the diagnosis and treatment of disorders related to parasitic infections.
Latest Patents
Andrea Johner holds 1 patent related to cyclic nucleotide-specific phosphodiesterases from parasites. The patent encompasses novel amino acid and nucleic acid sequences, as well as nucleic acid constructs, vectors, and host cells that incorporate these sequences. Furthermore, it details methods for producing and utilizing these sequences, along with the use of antibodies directed against them for diagnostic and therapeutic purposes.
Career Highlights
Throughout her career, Andrea has worked with esteemed institutions such as the University of Bern and Otsuka Pharmaceutical Company, Limited. Her research has focused on advancing our understanding of parasitic infections and developing innovative solutions to combat them.
Collaborations
Andrea Johner has collaborated with notable professionals in her field, including Thomas Seebeck and Yasmin Shakur. These partnerships have contributed to her research and the successful development of her patented technologies.
Conclusion
Andrea Johner's innovative work in the field of biotechnology highlights her commitment to advancing medical science. Her contributions, particularly in the area of nucleic acid sequences, have the potential to significantly impact the diagnosis and treatment of parasitic infections.